ATS
ABVX

Ashton Thomas Securities’s Abivax ABVX Stock Holding History

Ashton Thomas Securities’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278K Buy
+2,500
New +$296K 0.03% 306
2025
Q4 		– Sell
-2,500
Closed -$212K – 298
2025
Q3 		$212K Buy
+2,500
New +$153K 0.03% 307

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Ashton Thomas Securities's ABVX Position: Q1 2026 in Review

Ashton Thomas Securities opened a new position in Abivax (ABVX) in Q1 2026: 2,500 shares worth $278K. The stake represents 0.03% of the portfolio and ranks #306 among its holdings. This is a return to the name: Ashton Thomas Securities previously reported a position in ABVX as recently as Q3 2025.

Ashton Thomas Securities first reported a position in ABVX in Q3 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Ashton Thomas Securities held 2,500 shares of Abivax worth $278K as of Q1 2026.
  • Abivax was a new Ashton Thomas Securities position in Q1 2026.
  • Abivax made up 0.03% of Ashton Thomas Securities's portfolio in Q1 2026, its #306 holding.
  • Ashton Thomas Securities first reported a position in Abivax in Q3 2025 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Ashton Thomas Securities's 13F filing for Q1 2026, filed 18 May 2026.